Dashboard
Manage Tickers

FDMT


   

CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

Core News & Articles
10 Health Care Stocks Whale Activity In To...
10/08/2025 17:35:32

on-sept-30-4d-molecular-therapeutics-appointed-ashoo-gupta-as-principal-financial-officer-effective-immediately
On Sept 30, 4d Molecular Therapeutics Appo...
10/02/2025 20:12:01

-SEC Filing

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
09/04/2025 12:08:12

jim-cramer-applovin-calls-for-prudence-this-health-care-stock-is-pure-spec
Jim Cramer: AppLovin Calls For Prudence, T...
09/03/2025 11:46:59

Jim Cramer doesn't recommend buying more AppLovin stock. "Let's take a little off the table just to be prudent,"...

4d-molecular-therapeutics-says-4front-1-phase-3-trial-enrollment-continues-to-exceed-expectations-with-enrollment-completion-now-expected-in-q1-2026
4D Molecular Therapeutics Says 4FRONT-1 Ph...
09/02/2025 12:14:19

what-4-analyst-ratings-have-to-say-about-4d-molecular-therapeutics
What 4 Analyst Ratings Have To Say About 4...
08/12/2025 19:01:25

roth-capital-maintains-buy-on-4d-molecular-therapeutics-lowers-price-target-to-38
Roth Capital Maintains Buy on 4D Molecular...
08/12/2025 17:49:17

Roth Capital analyst Salveen Richter maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and lowers the price targe...

chardan-capital-maintains-buy-on-4d-molecular-therapeutics-maintains-25-price-target
Chardan Capital Maintains Buy on 4D Molecu...
08/12/2025 10:49:51

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and maintains $25 price...

4d-molecular-therapeutics-q2-eps-098-misses-085-estimate-sales-15000k-miss-374143k-estimate
4D Molecular Therapeutics Q2 EPS $(0.98) M...
08/11/2025 12:17:31

4D Molecular Therapeutics (NASDAQ:FDMT) reported quarterly losses of $(0.98) per share which missed the analyst consensus estim...

Core News & Articles
12 Health Care Stocks Moving In Monday's I...
08/04/2025 17:06:36

assessing-4d-molecular-therapeutics-insights-from-5-financial-analysts
Assessing 4D Molecular Therapeutics: Insig...
08/01/2025 22:04:04

4d-molecular-therapeutics-rallies-on-heels-of-diabetes-related-vision-study
4D Molecular Therapeutics Rallies On Heels...
08/01/2025 14:29:21

4D Molecular's 4D-150 showed sustained vision and anatomical improvements with fewer injections in DME, supported by regula...

Core News & Articles
12 Health Care Stocks Moving In Friday's P...
08/01/2025 12:07:59

Core News & Articles
Market-Moving News for August 1st
08/01/2025 11:15:14

FIG: 28% | Figma shares are trading higher on momentum following Thursday's IPO. COIN: -11% | Coinbase shares are trading l...

why-apple-shares-are-trading-higher-here-are-20-stocks-moving-premarket
Why Apple Shares Are Trading Higher; Here ...
08/01/2025 10:56:59

Core News & Articles
12 Health Care Stocks Moving In Thursday's...
07/31/2025 21:07:05

4dmt-presents-results-of-4d-150-spectra-clinical-trial-in-dme-and-regulatory-update
4DMT Presents Results Of 4D-150 SPECTRA Cl...
07/31/2025 20:25:24

4D-150 continues to be well tolerated with no intraocular inflammation observed at any timepoint or dose level4D-150 demonstrat...

what-4-analyst-ratings-have-to-say-about-4d-molecular-therapeutics
What 4 Analyst Ratings Have To Say About 4...
07/03/2025 19:01:16

chardan-capital-maintains-buy-on-4d-molecular-therapeutics-maintains-25-price-target
Chardan Capital Maintains Buy on 4D Molecu...
07/03/2025 12:05:08

Chardan Capital analyst Geulah Livshits maintains 4D Molecular Therapeutics (NASDAQ:FDMT) with a Buy and maintains $25 price...

4d-molecular-therapeutics-cuts-workforce-by-25-in-july-2025-to-save-15m-annually-extend-cash-runway-into-2028
4D Molecular Therapeutics Cuts Workforce B...
07/02/2025 20:22:35

Implemented a workforce reduction of approximately 25% of current and planned roles in July 2025, primarily in the areas suppor...

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION